Tesamorelin
5mg · 2ml
SKU: tesamorelin-5mg
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that activates pituitary GHRH receptors to increase endogenous growth hormone release and downstream IGF-1 production. It preserves natural feedback mechanisms while supporting enhanced lipolysis, protein synthesis, and metabolic signaling, particularly targeting visceral adipose tissue reduction.
Available Options
Product Specifications
Strength
5mg
Volume / Qty
2ml
Form
Lyophilized Powder
Dosing Guide
Recommended Dose
1-2 mg daily
Route
Subcutaneous
Frequency
Daily
Clinician Access Required
Sign in to view clinician pricing & place orders
Tesamorelin is available exclusively to verified clinicians under IRB-approved research protocol PPRN-001-2025.
IRB-Approved Research Protocol
PPRN-001-2025 ·IRCM-2025-467
Approved December 3, 2025 · Principal Investigator: Dr. M. Scott Mortensen, MD, MPAS, MLT
Save up to 80% with the 10,000 Growth Bundle
Tesamorelin is included in this clinic-tier package. Bundle includes higher volume in weight loss, mitochondrial health, longevity, and tissue repair with 1 free Tirz 15mg + 1 free Reta 15mg as a bonus.
Most popular
Also frequently ordered
What other clinicians put in the same cart.
For Clinicians
Clinical Reference
Pharmacology, safety, monitoring, and dosing reference for Tesamorelin. Always individualize based on patient context.
Mechanism of Action
Receptor / Target
Stabilized GHRH(1-44) analog; binds pituitary GHRH receptor
Half-Life
~26 minutes (subcutaneous)
Onset of Action
15 minutes for GH pulse; 12 weeks for visceral fat reduction
Metabolism
Hepatic and renal proteolysis
Cautions & Contraindications
Contraindicated In
- Active malignancy
- Pregnancy (Category X)
- Hypopituitarism, pituitary tumor, or recent pituitary surgery
- Hypersensitivity to tesamorelin or mannitol
Use Caution With
- Glucose intolerance and type 2 diabetes
- Fluid retention and arthralgias common in first 8 weeks
- Discontinue if no clinical benefit after 6 months
Suggested Labs to Monitor
IGF-1
Baseline / 6 weeksMaintain within age-appropriate normal range; reduce dose if elevated.
Fasting glucose, HbA1c
Baseline / 12 weeksLipid panel
Baseline / 12 weeksTesamorelin reduces triglycerides and visceral fat.
Lab interpretation guidance comes from peer-reviewed literature. Always individualize based on patient context.
Plumb DISCOVER
What Tesamorelin targets
Patient goals, biomarkers, and wearable signals this peptide addresses. Powers the future Plumb AI protocol engine.
Patient Goals
Biomarkers Tracked
Wearable Signals
Essential Protocol Packages
Tesamorelin is part of 1 clinical protocol
Bundle this peptide with synergistic compounds at clinic-tier pricing.
Related Products
Hexarelin 5mg
Synthetic growth hormone secretagogue with cardioprotective properties.
View Details
IGF-1 LR3 1mg
Long-acting insulin-like growth factor for muscle growth and recovery.
View Details
GHRP-2 10mg
Growth hormone releasing peptide-2 for GH secretion and appetite stimulation.
View Details
CJC-1295/Ipamorelin 10mg
CJC-1295/Ipamorelin is a synergistic combination of a synthetic GHRH analog and a selective growth hormone secretagogue that amplifies natural growth hormone release without excessive cortisol or prolactin stimulation. Together they promote increased IGF-1 production, cellular regeneration, fat metabolism, and deep sleep repair cycles.
View Details